New Delhi, Jan. 29 -- Piramal Pharma Q3 Results 2025:Piramal Pharma declared their Q3 results on 28 Jan, 2025, revealing a complex financial landscape. The company's topline experienced a positive growth of 12.54% year-over-year, yet the profit saw a dramatic decline of 63.6% year-over-year, amounting to Rs.3.68 crore. The revenue for the quarter reached Rs.2204.22 crore, highlighting a contrast in performance metrics.

In comparison to the previous quarter, there was a slight decline in revenue by 1.67%, while profit fell sharply by 83.71%. This raises concerns regarding the company's profitability amidst increasing operational costs.

The

Operating income took a hit, dropping by 5.66% compared to the previous quarter and a staggering 7...